Tofacitinib enhances delivery of antibody-based therapeutics to tumor cells through modulation of inflammatory cells

Nathan C. Simon(National Cancer Institute), David Fitzgerald(University of California San Diego)
JCI Insight
February 5, 2019
Cited by 23


Related Papers

No related papers found

Powered by citation graph analysis